Form 4: Sensus Healthcare Director Boosts Stake

Sensus Healthcare, Inc. Director Eric Sachetta acquired 2,500 shares of common stock at $4.50 per share, increasing his total beneficial ownership to 133,113 shares.

Summary

• Eric Sachetta, a Director of Sensus Healthcare, Inc. (SRTS), purchased 2,500 shares of common stock.
• The transaction occurred on November 13, 2025, at a price of $4.50 per share.
• Following this acquisition, Mr. Sachetta beneficially owns a total of 133,113 shares of Sensus Healthcare, Inc. common stock.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 7

Explanation: The purchase of company stock by a director is generally viewed as a positive signal, indicating confidence in the company's future prospects and aligning management's interests with shareholders.

Positives

• A company director, Eric Sachetta, purchased 2,500 shares of Sensus Healthcare common stock, indicating confidence in the company's future prospects.
• The acquisition increases the director's beneficial ownership, further aligning his interests with those of other shareholders.

Negatives

• No negative information is disclosed in this Form 4 filing.

Risks

• No specific risks are mentioned in this Form 4 filing.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

Insider purchases, such as this one by a director, are often interpreted by the market as a signal of management's confidence in the company's valuation and future performance, potentially indicating a belief that the stock is undervalued or poised for growth. This can be a positive indicator for investors, especially in the healthcare technology sector where Sensus Healthcare operates.

Related Party Transactions

• Director Eric Sachetta purchased 2,500 shares of Sensus Healthcare, Inc. common stock from the open market, which is a standard related-party transaction reported under Section 16(a) of the Securities Exchange Act of 1934.

Stakeholder Impact

• Shareholders may view this insider purchase as a positive indicator of management's belief in the company's value and future performance, potentially boosting investor confidence.

Key Dates

Recommendation

While the insider purchase by a director is a positive signal, indicating management's confidence in Sensus Healthcare, Inc., a single transaction of this size typically warrants a 'hold' recommendation rather than a 'buy' without additional supporting fundamental analysis or significant news. It suggests a favorable outlook but isn't a standalone catalyst for a strong buy.

Keywords

Sensus Healthcare, SRTS, Insider Buying, Form 4, Director Stock Purchase, Equity Acquisition, Beneficial Ownership, Rule 10b5-1